ArticlePharmaceutics2025

Systematic Development and Characterization of Enzyme-Free, Borax-Crosslinked Microneedles for Glucose-Responsive Insulin Delivery and In Vivo Glycemic Mitigation.

Cuc Thi Dinh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.